Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07404982 · ClinicalTrials.gov registry record · Phase 2
Reversal of Spinal Anesthesia Residual Motor Block Via Intrathecal Catheter
A Phase 2 study of Joint Replacement Surgery, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07404982 is a Phase 2 study of Joint Replacement Surgery that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07404982, a Phase 2 study of Joint Replacement Surgery, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the feasibility of administering a predetermined amount of normal saline into the intrathecal or subarachnoid space via a small spinal catheter to reduce or eliminate the effects of previously injected spinal anesthetic following lower extremity orthopedic surgery.
Conditions Studied
Interventions
- DRUG Normal Saline 10 mL Injection
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07404982
The ClinicalTrials.gov registry entry for NCT07404982 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Joint Replacement Surgery appearing as the primary indexed condition, and to 1 intervention - of which Normal Saline 10 mL Injection is the first listed.
NCT07404982 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07404982 about?
NCT07404982 is a clinical study titled "Reversal of Spinal Anesthesia Residual Motor Block Via Intrathecal Catheter". The purpose of this study is to determine the feasibility of administering a predetermined amount of normal saline into the intrathecal or subarachnoid space via a small spinal catheter to reduce or eliminate the effects of previously injected spinal anesthetic following lower extremity orthopedic s...
What is the current status of trial NCT07404982?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2026-02. Estimated completion is 2027-12.
What conditions does trial NCT07404982 study?
This clinical trial studies the following conditions: Joint Replacement Surgery.
What interventions are being tested in trial NCT07404982?
The interventions under investigation include: Normal Saline 10 mL Injection (DRUG).
Who is sponsoring clinical trial NCT07404982?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07404982 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.